Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using a cDNA probe for the gamma gene of
protein kinase C
(
PKCG
), an informative RFLP with a PIC value of 0.62 has been identified with the enzyme MspI. The polymorphic bands have been assigned to chromosome 19. Analysis of the segregation of alleles for this probe in myotonic dystrophy families show several recombinants between
PKCG
and myotonic dystrophy (DM) and exclude this gene as a candidate for DM. Linkage relationships between
PKCG
and other loci on chromosome 19 are presented which exclude
PKCG
from the proximal region of chromosome 19 and which are consistent with the localization being at 19q13.2----qter.
...
PMID:Linkage relationships of the protein kinase C gamma gene which exclude it as a candidate for myotonic dystrophy. 246 Feb 93
The hypothesis that
protein kinase C
(
PKC
) is able to regulate the whole cell Ca-activated K (KCa) current independently of
PKC
effects on local Ca release events was tested using the patch-clamp technique and freshly isolated rat tail artery smooth muscle cells dialyzed with a strongly buffered low-Ca solution. The active diacylglycerol analog 1,2-dioctanoyl-sn-glycerol (DOG) at 10 microM attenuated the current-voltage (I-V) relationship of the KCa current significantly and reduced the KCa current at +70 mV by 70 +/- 4% (n = 14). In contrast, 10 microM DOG after pretreatment of the cells with 1 microM calphostin C or 1 microM
PKC
inhibitor peptide, selective
PKC
inhibitors, and 10 microM 1,3-dioctanoyl-sn-glycerol, an inactive diacylglycerol analog, did not significantly alter the KCa current. Furthermore, the catalytic subunit of
PKC
(
PKCC
) at 0.1 U/ml attenuated the I-V relationship of the KCa current significantly, reduced the KCa current at +70 mV by 44 +/- 3% (n = 17), and inhibited the activity of single KCa channels at 0 mV by 79 +/- 9% (n = 6). In contrast, 0.1 U/ml heat-inactivated
PKCC
did not significantly alter the KCa current or the activity of single KCa channels. Thus these results suggest that
PKC
is able to considerably attenuate the KCa current of freshly isolated rat tail artery smooth muscle cells independently of effects of
PKC
on local Ca release events, most likely by a direct effect on the KCa channel.
...
PMID:Protein kinase C reduces the KCa current of rat tail artery smooth muscle cells. 1006 92
Two of the most effective stimuli of gastrin release from human antral G cells are bombesin and phorbol esters. Both agonists result in activation of the
protein kinase C
family of isozymes, however, the exact contribution of
protein kinase C
to the resultant release of gastrin has been difficult to assess, possibly due to the presence of multiple
protein kinase C
isozymes in the G cells. The results of the present study demonstrated that the human antral G cells expressed 6
protein kinase C
isozymes alpha, gamma, theta, epsilon, zeta, and mu. Of these
protein kinase C, gamma
and theta were translocated by stimulation of the cells by either 10 nM bombesin or 1 nM phorbol ester. Inhibition of protein kinase Cmu (localized to the Golgi complex) did not decrease bombesin-stimulated gastrin release indicating that this isozyme was not involved in the secretory process. The use of selective antagonists of the calcium-sensitive conventional
protein kinase C
subgroup resulted in an increase in bombesin-stimulated gastrin release and indicated that protein kinase Cgamma was involved in the desensitization of the bombesin response.
...
PMID:The role of protein kinase C isozymes in bombesin-stimulated gastrin release from human antral gastrin cells. 1042 25
The underlying pathogenesis of stroke is mediated by a variety of environmental risk factors as well as genetic ones. Thus, we have to evaluate the environmental factors precisely to identify the stroke-related gene polymorphisms. The Hisayama study, an epidemiological study of cardiovascular diseases, was established in 1961 in Hisayama, Japan. In 2002, a screening survey for the genetic study was performed in Hisayama. The Fukuoka Stroke Registry (FSR) is a hospital-based registration of stroke patients. Stroke specialists from eight medical centers in southern Japan have participated in FSR. In the present study, control and case subjects were recruited from the Hisayama study and FSR, respectively. We performed a genome-wide case-control study and found that a nonsynonymous SNP in PRKCH encoding a member of
protein kinase C
(
PKCC
eta) was significantly associated with brain infarction. As a candidate gene analysis, we investigated the role of NAD (P) H oxidase C242T polymorphism in the development of brain infarction. The C242T polymorphism was not associated with lacunar and atherothrombotic infarction; however, the presence of T-allele may have a protective role in the occurrence of atrial fibrillation and cardioembolic brain infarction. These studies may provide important information for the development of the therapeutic strategies against stroke.
...
PMID:[Molecular epidemiology of cerebrovascular diseases; the Hisayama study and the Fukuoka Stroke Registry (FSR)]. 1919 8